MedTrace Logo

Parathyroid Adenoma Detection With Rubidium-82 Imaging

NCT07099404 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-08-22

No results posted yet for this study

Summary

Assess the uptake of rubidium-82 in parathyroid adenomas.

Conditions

  • Parathyroid Adenomas
  • Hyperparathyroidism, Primary

Interventions

OTHER

PET/CT imaging with rubidium-82

PET imaging of the neck will be started immediately before infusion of 10 Megabecquerels per kilograms of rubidum-82 over 30 seconds. The acquisition will last 10 minutes. This will be followed by a non-contrast low-dose CT of the neck for localization and attenuation correction.

Sponsors & Collaborators

  • Matthieu Pelletier-Galarneau, MD MSc

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-30
Primary Completion
2027-09-30
Completion
2028-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07099404 on ClinicalTrials.gov